Providence First Trust Co Invests $943,000 in Lam Research Corporation $LRCX

Providence First Trust Co acquired a new position in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 5,507 shares of the semiconductor company's stock, valued at approximately $943,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Generali Investments Management Co LLC grew its position in Lam Research by 62.0% during the fourth quarter. Generali Investments Management Co LLC now owns 36,274 shares of the semiconductor company's stock valued at $6,209,000 after acquiring an additional 13,878 shares during the last quarter. Lingohr Asset Management GmbH lifted its holdings in shares of Lam Research by 590.7% during the third quarter. Lingohr Asset Management GmbH now owns 59,555 shares of the semiconductor company's stock valued at $7,974,000 after purchasing an additional 50,933 shares during the last quarter. Mediolanum International Funds Ltd grew its holdings in shares of Lam Research by 52.0% during the third quarter. Mediolanum International Funds Ltd now owns 262,544 shares of the semiconductor company's stock valued at $34,417,000 after buying an additional 89,856 shares during the last quarter. First Citizens Bank & Trust Co. raised its stake in shares of Lam Research by 8.0% in the third quarter. First Citizens Bank & Trust Co. now owns 140,433 shares of the semiconductor company's stock worth $18,804,000 after purchasing an additional 10,408 shares during the last quarter. Finally, Thoroughbred Financial Services LLC boosted its position in shares of Lam Research by 115.2% during the third quarter. Thoroughbred Financial Services LLC now owns 22,198 shares of the semiconductor company's stock valued at $2,972,000 after buying an additional 11,883 shares during the last quarter. 84.61% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, SVP Neil J. Fernandes sold 18,170 shares of the stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of $255.14, for a total value of $4,635,893.80. Following the completion of the sale, the senior vice president directly owned 66,129 shares of the company's stock, valued at approximately $16,872,153.06. This represents a 21.55% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 35,000 shares of the firm's stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the sale, the director owned 253,705 shares in the company, valued at approximately $57,235,848. The trade was a 12.12% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 155,066 shares of company stock valued at $35,849,242. Insiders own 0.31% of the company's stock.

Lam Research Price Performance

Shares of Lam Research stock opened at $275.80 on Wednesday. The stock has a market cap of $344.91 billion, a P/E ratio of 52.04, a P/E/G ratio of 2.14 and a beta of 1.81. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.77 and a current ratio of 2.54. The stock's fifty day moving average is $236.99 and its 200 day moving average is $202.86. Lam Research Corporation has a one year low of $72.59 and a one year high of $280.00.

Lam Research (NASDAQ:LRCX - Get Free Report) last released its quarterly earnings results on Wednesday, April 22nd. The semiconductor company reported $1.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.11. Lam Research had a return on equity of 66.21% and a net margin of 30.94%.The business had revenue of $5.84 billion during the quarter, compared to analyst estimates of $5.70 billion. During the same quarter in the previous year, the company posted $1.04 earnings per share. Lam Research's revenue for the quarter was up 23.8% on a year-over-year basis. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. Sell-side analysts anticipate that Lam Research Corporation will post 5.68 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research firms have commented on LRCX. Citigroup reaffirmed a "buy" rating and issued a $315.00 target price (up from $300.00) on shares of Lam Research in a research report on Thursday, April 23rd. Citic Securities raised their price target on Lam Research from $165.00 to $275.00 and gave the stock a "buy" rating in a research note on Friday, January 30th. Berenberg Bank lifted their price objective on Lam Research from $265.00 to $335.00 and gave the stock a "buy" rating in a report on Thursday, April 23rd. Needham & Company LLC reiterated a "buy" rating and set a $300.00 price objective on shares of Lam Research in a research report on Thursday, April 23rd. Finally, Barclays set a $275.00 target price on Lam Research and gave the company an "equal weight" rating in a report on Thursday, April 23rd. Twenty-six equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, Lam Research has an average rating of "Moderate Buy" and a consensus target price of $285.94.

Key Headlines Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Earnings beat + bullish near‑term guide — Lam reported a March‑quarter revenue and EPS beat and gave an upbeat June‑quarter outlook, which the market interpreted as accelerating wafer‑fab demand and margin expansion. Lam Research jumps 7% as earnings beat and June-quarter outlook signals accelerating wafer-fab demand
• Positive Sentiment: TAM and secular demand lift the investment case — Analysts and commentators raised WFE and hyperscaler‑capex forecasts (Lam’s environment looks larger), reinforcing growth expectations and the claim that AI-driven device complexity benefits Lam’s etch/deposition exposure. Lam Research: $140B WFE, $725B In Hyperscaler Capex, And Still Raising -- BUY
• Positive Sentiment: Analyst target upgrades and bullish notes — Multiple firms have raised price targets and reiterated Outperform/Buy calls after the quarter, supporting momentum and upside thesis. Lam Research (LRCX) Surges to Record Highs: Analyzing the 252% Rally
• Positive Sentiment: Technical breakout / IBD recognition — The stock cleared an IBD buy point after the strong report, drawing momentum and retail/institutional interest. Lam Research, IBD Stock Of The Day, Clears Buy Point On Chip-Gear Investments
• Neutral Sentiment: Insider sale disclosed — An SVP sold ~18k shares under a pre‑arranged Rule 10b5‑1 plan; routine disclosure but worth noting for timing/context. Insider Selling: Lam Research NASDAQ: LRCX SVP Sells 18,170 Shares of Stock
• Neutral Sentiment: Valuation and “froth” commentary — Some analysis flags stretched multiples and consolidation risk after the run; elevated P/E requires investors to weigh growth vs. premium valuation. Lam Research Is Approaching Frothy Levels
• Negative Sentiment: Insider and institutional selling activity — Reports show multiple executive sales and notable institutional repositioning in recent quarters; while some are pre‑planned or rebalancing, sustained selling can temper sentiment if it continues. Lam Research jumps 7% as earnings beat and June-quarter outlook signals accelerating wafer-fab demand

Lam Research Company Profile

Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.